Research & Clinical Trials ·
Linq Minerals Reports 429m Mineralised Zone at Gidginbung South in Gilmore Project
Linq Minerals drilled a 429m mineralised zone at Gidginbung South, 800m beyond the known limit, with final assays due within two months.
Business news for Wednesday, October 21, 2026
22 stories: 3 research updates, 3 product launches and 3 funding rounds. Newest first, times in UTC.
Research & Clinical Trials ·
Actinogen Medical enters database lock on 247-patient XanaMIA Alzheimer's trial
Actinogen Medical has locked the XanaMIA trial database after 247 patients finished the 36-week study, with topline results due in mid-November.
Product Launches ·
Bubs Australia Returns Infant Formula to Vietnam Shelves After Packaging Refresh
Bubs Australia relaunches infant formula in Vietnam after packaging updates, resuming distribution through HC Pharma and hosting a Hanoi nutrition conference.
Incidents ·
Google Removes Some Fake One-Star Reviews After Cellar Creations Appears on The Block
Google deleted some fake one-star reviews after Cellar Creations appeared on The Block, leaving three one-star ratings and dozens of Facebook comments.
Legal & Disputes ·
Cotchett, Pitre & McCarthy Sues Levi Strauss Over Tariff Refunds It Kept
Cotchett, Pitre & McCarthy filed a class action against Levi Strauss over $79 million in tariff refunds the company kept after raising consumer prices.
Product Launches ·
BRAC Bank Goes Live With Finastra Trade Innovation and Corporate Channels
BRAC Bank has gone live with Finastra's Trade Innovation and Corporate Channels plus Conpend's Trade AI.
Funding ·
NTT Docomo Ventures Invests in Kaminashi to Digitize Non-Desk Work
NTT Docomo Ventures has invested in Kaminashi, the Tokyo startup behind the Kaminashi Report, to expand AI tools for non-desk workers in manufacturing.
Regulation & Approvals ·
Frontier Energy Gets 99MW Reserve Capacity Credit for Waroona Stage One
AEMO raised Frontier Energy's Waroona Stage One reserve capacity credit to 99MW, lifting annual payments to $36 million and average yearly revenue to $76 million.
Earnings & Results ·
Revolve Renewable Power Widens FY2026 Net Loss to $4.87 Million as Revenue Falls
Revolve Renewable Power reported a $4.87 million FY2026 net loss and $2.395 million revenue, while drawing on a $24 million Mexico facility and closing two asset deals.
Legal & Disputes ·
Wolf Popper Continues Xenon Pharmaceuticals Investor Investigation After 30.7% Stock Drop
Wolf Popper LLP is continuing its investigation into potential claims for Xenon Pharmaceuticals investors after a 30.7% stock drop on September 18, 2026.
Business ·
Salvi, Schostok & Pritchard Places 19 Attorneys on 2027 Illinois Super Lawyers and Rising Stars Lists
Nineteen Salvi, Schostok & Pritchard attorneys made the 2027 Illinois Super Lawyers and Rising Stars lists.
Research & Clinical Trials ·
Cleo Diagnostics Ovarian Cancer Test Beats Screening Benchmarks in First Proof-of-Concept Study
Cleo Diagnostics' prototype ovarian cancer test hit 92.2% sensitivity in a 247-woman study, clearing pre-set screening thresholds ahead of larger cohort testing.
Funding ·
Dios Exploration Launches $600,005 Flow-Through Placement for Heberto-Gold Drilling
Dios Exploration is raising up to $600,005 through a non-brokered flow-through private placement to fund diamond drilling at its Heberto-Gold property in Quebec.
Funding ·
NAVER D2SF Invests in TraceWeave as On-Device AI Startup Raises KRW 3 Billion Seed
NAVER D2SF invested in TraceWeave, whose Phase-TITAN architecture keeps memory constant, in a seed round led by Mirae Asset Capital worth about KRW 3 billion.
Partnerships ·
HUTCHMED Closes GSK License for HMPL-A830 Outside China With $110 Million Upfront
HUTCHMED closed its GSK license for HMPL-A830, expecting $110 million upfront and up to $1.185 billion in milestones for the KRAS-EGFR conjugate.
Earnings & Results ·
Moody's Assigns Provisional Baa1 to Samruk-Kazyna's $1.5 Billion Note Programme
Moody's assigned a provisional Baa1 rating to Samruk-Kazyna's $1.5 billion senior unsecured note programme, with Baa1 ratings on three proposed issuances.
Regulation & Approvals ·
Ascentage Pharma's Lisaftoclax Wins China Breakthrough Therapy Designation in First-Line CLL/SLL
Ascentage Pharma's lisaftoclax with acalabrutinib won a China Breakthrough Therapy Designation for treatment-naïve CLL/SLL.
Expansion ·
Western Sydney International Airport Adds Two 3D X-ray Units Before First International Arrival
Western Sydney International Airport received two 3D X-ray units and detector dog teams ahead of its first international arrival on 26 October 2026.
Expansion ·
Conner Homes Opens Greenview Heights, an 84-Townhome Community in Snohomish County
Conner Homes opened sales at Greenview Heights, an 84-townhome Snohomish County community priced from the $600,000s, with a grand opening on October 24.
Expansion ·
Allens Advises Engie Australia on Second Stage of Hazelwood Battery Storage Expansion
Allens advised Engie Australia on the second stage of the Hazelwood battery, adding 150MW/300MWh and lifting site capacity to 300MW/450MWh in Victoria.
Product Launches ·
Lidl GB to give 100 shoppers a £600 Middle of Lidl Blue Card
Lidl GB will give 100 Lidl Plus members a £600 Middle of Lidl Blue Card, worth £50 a month for a year, through a quiz open from October 21 to 31.
Earnings & Results ·
Mitsubishi Motors Philippines Aims to Match 86,808 Units in 2026 as Market Contracts
Mitsubishi Motors Philippines targets 86,808 units in 2026 after an 20.3% eight-month sales decline, as the Philippine auto market heads for its first contraction in six years.